Cochrane Abstracts
Pharmacological interventions for non‐alcohol related fatty liver disease (NAFLD)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Pharmacological Interventions for Non‐alcohol Related Fatty Liver Disease (NAFLD)." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436809/all/Pharmacological_interventions_for_non‐alcohol_related_fatty_liver_disease__NAFLD_.
Pharmacological interventions for non‐alcohol related fatty liver disease (NAFLD). Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436809/all/Pharmacological_interventions_for_non‐alcohol_related_fatty_liver_disease__NAFLD_. Accessed March 15, 2025.
Pharmacological interventions for non‐alcohol related fatty liver disease (NAFLD). (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436809/all/Pharmacological_interventions_for_non‐alcohol_related_fatty_liver_disease__NAFLD_
Pharmacological Interventions for Non‐alcohol Related Fatty Liver Disease (NAFLD) [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436809/all/Pharmacological_interventions_for_non‐alcohol_related_fatty_liver_disease__NAFLD_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Pharmacological interventions for non‐alcohol related fatty liver disease (NAFLD)
ID - 436809
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436809/all/Pharmacological_interventions_for_non‐alcohol_related_fatty_liver_disease__NAFLD_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
